The Accelerated Phase of Chediak-Higashi Syndrome: The Importance of Hematological Evaluation
Journal Title: Turkish Journal of Hematology - Year 2013, Vol 30, Issue 1
Abstract
Chediak-Higashi syndrome is a rare autosomal recessive disease that was first described in 1943 by Bequez-Cesar in 3 siblings that bore the primary clinical features. In 1952 Chediak (a Cuban hematologist) and in 1954 Higashi (a Japanese pediatrician) described a series of cases characterized by misdistribution of myeloperoxidase in the patients’ neutrophilic granules [1,2].
Authors and Affiliations
Shreekant Bharti, Prateek Bhatia, Deepak Bansal, Neelam Varma
Keywords
Related Articles
- EP ID EP163412
- DOI 10.4274/tjh.2012.0027
- Views 90
- Downloads 0
Late Side Effects of Chemotherapy and Radiotherapy in Early Childhood on the Teeth: Two Case Reports
.
Pediatrik Akut Miyeloid Lösemili Hastada Yüksek Doz Sitarabin Uygulamasına Bağlı Korneal Epitel Mikrokistler
Rituximab-Related Reversible Hepatocellular Damage
To the Editor, Since its approval in 1997 by the US Food and Drug Administration, use of rituximab (MabThera®, Roche,Switzerland) has become widespread, especially for the treatment of non-Hodgkin lymphoma (NHL) and chr...
Acquired Hemophilia
Carbamazepine-induced Red Blood Cell Aplasia: A Case Report
To the Editor, A 2-year-old boy developed pure red cell aplasia (PRCA) during carbamazepine (CBZ) therapy. There was no history of prolonged or profuse bleeding after cuts or injury, and no bleeding from any sites of th...